G Medical Innovations Holdings Ltd. Ordinary Shares
GMVD
GMVD was delisted on the 23rd of August, 2023.
7 hedge funds and large institutions have $522K invested in G Medical Innovations Holdings Ltd. Ordinary Shares in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 0 closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
26% less capital invested
Capital invested by funds: $709K → $522K (-$187K)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$7.98K |
| 2 |
SSA
Schonfeld Strategic Advisors
New York
|
+$6.86K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$3.43K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFI
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
|
-$23K |
| 2 |
TCM
Tradewinds Capital Management
Bellingham,
Washington
|
-$2.16K |
| 3 |
JP Morgan Chase
New York
|
-$448 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SSA
1
Schonfeld Strategic Advisors
New York
| $208K | +$6.86K | +92 | +3% |
|
2
Geode Capital Management
Boston,
Massachusetts
| $124K | – | – | – |
|
|
3
JP Morgan Chase
New York
| $101K | -$448 | -6 | -0.3% |
|
|
SFI
4
Susquehanna Fundamental Investments
Bala Cynwyd,
Pennsylvania
| $41K | -$23K | -308 | -30% |
|
|
TCM
5
Tradewinds Capital Management
Bellingham,
Washington
| $33K | -$2.16K | -29 | -5% |
|
|
6
UBS Group
Zurich,
Switzerland
| $12K | +$7.98K | +107 | +115% |
|
|
7
Bank of America
Charlotte,
North Carolina
| $3K | +$3.43K | +46 | New |
|
GMVD Hedge Fund Activity: Q4 2021 in Review
7 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) for Q4 2021, worth a combined $522K — down 26% from $709K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new GMVD positions and 0 closed out — a net gain of 1 holder — while 2 added to existing stakes and 3 trimmed.
The largest buyer was UBS Group, adding an estimated $7.98K. The largest seller was Susquehanna Fundamental Investments, cutting an estimated $23K.
- 7 institutional investors held G Medical Innovations Holdings Ltd. Ordinary Shares (GMVD) as of Q4 2021, up from 6 in Q3 2021.
- Funds reported $522K of G Medical Innovations Holdings Ltd. Ordinary Shares stock for Q4 2021, down 26% quarter-over-quarter.
- 1 fund opened new G Medical Innovations Holdings Ltd. Ordinary Shares positions in Q4 2021 and 0 closed out, a net change of +1 holder.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares buyer in Q4 2021 was UBS Group, an estimated $7.98K added.
- The largest G Medical Innovations Holdings Ltd. Ordinary Shares seller in Q4 2021 was Susquehanna Fundamental Investments, an estimated $23K sold.
Based on aggregated 13F filings for Q4 2021.